IGFBP7 and acute kidney injury: In patients progressing to AKI stages 2–3, the concentrations of urinary [TIMP-2] • [IGFBP7] surged on the day of exposure, displaying a distinct pattern of rise and subsequent decline surrounding the majority of exposures [25].